Department of Surgery, University of Michigan, Ann Arbor.
Center for Healthcare Outcomes and Policy, School of Medicine, University of Michigan, Ann Arbor.
JAMA Netw Open. 2020 Apr 1;3(4):e203850. doi: 10.1001/jamanetworkopen.2020.3850.
Despite growing interest from various surgical societies and patient safety organizations, concerns remain that volume-based credentialing standards are arbitrary and may fail to recognize a surgeon's full scope of practice.
To evaluate whether surgeon experience with related procedures was associated with better outcomes for pancreaticoduodenectomy compared with procedure-specific experience alone.
DESIGN, SETTING, AND PARTICIPANTS: This proof-of-concept cohort study used the all-payer State Inpatient Databases from 6 geographically diverse states to identify all operations for surgeons who performed at least 1 pancreaticoduodenectomy from January 1, 2012, to December 31, 2014. Each surgeon's mean annual volume for pancreaticoduodenectomies and related complex hepatopancreatobiliary (HPB) procedures was calculated. Outcomes for surgeons above and below a threshold of 12 pancreaticoduodenectomies per year were evaluated. Whether related HPB procedure volume was also associated with better outcomes for surgeons not meeting the procedure-specific threshold was also evaluated. Data were analyzed from March 2 through 20, 2019.
Thirty-day mortality and complications.
The study cohort included 176 043 patients, of whom 92 064 were female (52.3%), with a mean (SD) age of 59 (17) years. Within 270 hospitals, only 54 of 1028 surgeons (5.3%) met the mean pancreaticoduodenectomy volume threshold from 2012 to 2014. In-hospital mortality after pancreaticoduodenectomy was lower for surgeons who performed 12 or more procedures per year (1.8% [95% CI, 1.1%- 2.4%] vs 4.7% [95% CI, 4.0%-5.4%]; odds ratio, 0.32; 95% CI, 0.21-0.50). However, in-hospital mortality varied 7-fold among surgeons who did not meet the threshold (1.2% [95% CI, 0.8%-1.6%] to 8.4% [95% CI, 7.9%-8.9%]). Increasing HPB case volume was associated with better outcomes for pancreaticoduodenectomy in this group. For example, surgeons performing 2 or fewer pancreaticoduodenectomies annually would need to perform an additional 27 related HPB procedures to match the in-hospital mortality rate of surgeons performing 12 or more pancreaticoduodenectomies.
In this proof-of-concept cohort study, few surgeons met even modest annual volume thresholds for pancreaticoduodenectomy. The findings suggest that inclusion of related procedure volumes may safely expand the cohort of surgeons credentialed to perform certain procedures under volume-based standards.
尽管来自各个外科协会和患者安全组织的兴趣日益增加,但人们仍然担心基于量的认证标准是任意的,并且可能无法认识到外科医生的全部实践范围。
评估与胰腺十二指肠切除术相关的手术经验是否与仅与特定手术相关的经验相比,与更好的结果相关。
设计、设置和参与者:本概念验证队列研究使用了来自 6 个地理位置不同的州的全付费州住院患者数据库,以确定至少进行过一次胰腺十二指肠切除术的外科医生进行的所有手术。计算每位外科医生的胰腺十二指肠切除术和相关复杂肝胆胰(HPB)手术的平均年度手术量。评估每年进行 12 次以上胰腺十二指肠切除术的外科医生和低于该阈值的外科医生的结果。还评估了相关 HPB 手术量是否也与不符合特定手术阈值的外科医生的更好结果相关。数据于 2019 年 3 月 2 日至 20 日进行分析。
30 天死亡率和并发症。
研究队列包括 176043 名患者,其中 92064 名女性(52.3%),平均年龄(标准差)为 59(17)岁。在 270 家医院中,只有 1028 名外科医生中的 54 名(5.3%)达到了 2012 年至 2014 年的平均胰腺十二指肠切除术量阈值。每年进行 12 次或更多手术的外科医生的胰腺十二指肠切除术后院内死亡率较低(1.8%[95%CI,1.1%-2.4%]与 4.7%[95%CI,4.0%-5.4%];比值比,0.32;95%CI,0.21-0.50)。然而,未达到该阈值的外科医生的院内死亡率相差 7 倍(1.2%[95%CI,0.8%-1.6%]至 8.4%[95%CI,7.9%-8.9%])。该组中,HPB 病例量的增加与胰腺十二指肠切除术的更好结果相关。例如,每年进行 2 次或更少胰腺十二指肠切除术的外科医生需要再进行 27 次相关的 HPB 手术,才能达到每年进行 12 次或更多胰腺十二指肠切除术的外科医生的院内死亡率。
在本概念验证队列研究中,很少有外科医生甚至达到了胰腺十二指肠切除术的适度年度量的阈值。研究结果表明,纳入相关手术量可能会安全地扩大根据基于量的标准获得某些手术认证的外科医生的队列。